A dual variable Markov model to assess the potential benefits of choroideremia gene therapy on quality adjusted life years (QALYs)
| Main Authors: | , , , , |
|---|---|
| Format: | Conference item |
| Published: |
Association for Research in Vision and Ophthalmology (ARVO)
2018
|